Therapeutic applications of bioactive sphingolipids in hematological malignancies. - Wikidata - awgldk - TriplyDB

Therapeutic applications of bioactive sphingolipids in hematological malignancies.

Therapeutic applications of bioactive sphingolipids in hematological malignancies.

http://www.wikidata.org/entity/Q37760875

about

Elisidepsin Interacts Directly with Glycosylceramides in the Plasma Membrane of Tumor Cells to Induce Necrotic Cell Death Inhibition of sphingosine kinase 2 downregulates the expression of c-Myc and Mcl-1 and induces apoptosis in multiple myeloma.Triangulated mal-signaling in Alzheimer's disease: roles of neurotoxic ceramides, ER stress, and insulin resistance reviewed Sphingosine kinase 1 is a potential therapeutic target for nasopharyngeal carcinoma.Therapeutic potential of targeting ceramide/glucosylceramide pathway in cancer.Changes in molecular biology of chronic myeloid leukemia in tyrosine kinase inhibitor era.Microbubble-based enhancement of radiation effect: Role of cell membrane ceramide metabolism.Increased ceramide production sensitizes breast cancer cell response to chemotherapy.Bioactive lipids-based pH sensitive micelles for co-delivery of doxorubicin and ceramide to overcome multidrug resistance in leukemia.The combination of a sphingosine kinase 2 inhibitor (ABC294640) and a Bcl-2 inhibitor (ABT-199) displays synergistic anti-myeloma effects in myeloma cells without a t(11;14) translocation.Sphingosine but not sphingosine-1-phosphate stimulates suicidal erythrocyte death.Multiple Roles of Glycans in Hematological Malignancies

P2860

Q27312540-6965A3C3-8AA8-4F39-B886-8AEF290E2573 Q34209320-84263430-276C-453E-9EC9-8D71019B12DC Q35997884-7EB3DB77-5E8F-4CE6-BAF8-D34CCAB1A0E4 Q37697046-B56CBD05-6907-4531-88DF-8BFCEDD6F20B Q38052818-E80F40EB-8E16-4AA7-BBF2-0B530E91FF09 Q38133575-B38D4D51-A3B0-44E7-AD69-A422144BD7BE Q38660182-3D496217-5A93-4EC8-9495-EB57A6E85440 Q38709652-A70F2426-11F3-4E1E-89C0-5E296FC2647C Q39136118-FCDB368B-265B-430C-9838-A5760A4E2A6D Q53682262-2D0E4732-F899-4438-9FEE-1F117CE23222 Q54565672-BDE1F808-8E88-4EF7-8AFE-506C4C6BD289 Q58761454-2B22A26C-898A-4CF9-AE75-FBD006F95688

P2860

Therapeutic applications of bioactive sphingolipids in hematological malignancies.

http://www.wikidata.org/entity/Q37760875

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Therapeutic applications of bioactive sphingolipids in hematological malignancies.

@en

Therapeutic applications of bioactive sphingolipids in hematological malignancies.

@nl

type

label

Therapeutic applications of bioactive sphingolipids in hematological malignancies.

@en

Therapeutic applications of bioactive sphingolipids in hematological malignancies.

@nl

prefLabel

Therapeutic applications of bioactive sphingolipids in hematological malignancies.

@en

Therapeutic applications of bioactive sphingolipids in hematological malignancies.

@nl

P1433

Q37760875-4C73CE5E-E70B-4DAF-93F1-C53513224CD2

P1476

Q37760875-8B0C1493-CFCC-4D5B-9B68-F88C4C4AAB86

P2093

Q37760875-C1C9381A-D2AF-4B04-B17F-98A667E34369

Q37760875-F86029F6-C6D4-4A36-A597-1C72E9C7839C

P2860

Q37760875-01F366ED-DA09-431C-B250-E88E76412CD7

Q37760875-0589464A-A9AD-413A-8A94-C2A9A7C776D2

Q37760875-06584201-9274-4E8A-8206-61B9CAB655B9

Q37760875-08D1587B-256D-4A3A-B60C-C101DC9EBE09

Q37760875-0F738F24-8A64-40E8-8173-799255F18E08

Q37760875-100C9FC6-9173-4AAF-B796-C6DBE34788E1

Q37760875-11929E96-82A8-470B-90F4-84B951A6A131

Q37760875-14855450-9ED0-4C7A-8165-046E62294581

Q37760875-15DD155A-0DFC-4CDA-9F2C-FFC891C14654

Q37760875-1CE0CB61-DA11-435E-B819-76194B2DF7B6

P304

Q37760875-254F7D90-AFA2-4A77-89F0-DE3AB238DF2C

P31

Q37760875-EB4048F2-FDE3-48B0-B890-E07E43CB171E

P356

Q37760875-4903C0D2-8BEB-45A0-B464-C41963CD3F67

P433

Q37760875-FEA2A25E-B690-4739-8192-40CED01CF067

P478

Q37760875-E72F030B-9293-4C1B-A90B-6F8A4F282080

P577

Q37760875-6E1A8F3F-E2F8-449F-A56B-AD3C9C57FAE0

P5875

Q37760875-5028D24A-8A3A-4BB0-A935-149871445E24

P698

Q37760875-C94CC52D-27E0-4D0F-851F-9B7685069D4F

P356

P1433

International Journal of Cancer

P1476

Therapeutic applications of bioactive sphingolipids in hematological malignancies.

@en

P2093

Huseyin Atakan Ekiz

http://www.w3.org/2001/XMLSchema#string

Yusuf Baran

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform

Ceramide kinase, a novel lipid kinase. Molecular cloning and functional characterization

Alkaline ceramidase 3 (ACER3) hydrolyzes unsaturated long-chain ceramides, and its down-regulation inhibits both cell proliferation and apoptosis

Golgi alkaline ceramidase regulates cell proliferation and survival by controlling levels of sphingosine and S1P

Alkaline ceramidase 2 regulates beta1 integrin maturation and cell adhesion

Retinoblastoma gene product as a downstream target for a ceramide-dependent pathway of growth arrest

The sphingolipid salvage pathway in ceramide metabolism and signaling

A house divided: ceramide, sphingosine, and sphingosine-1-phosphate in programmed cell death

Serine palmitoyltransferase regulates de novo ceramide generation during etoposide-induced apoptosis

Sphingosine-1-phosphate and its potentially paradoxical effects on critical parameters of cutaneous wound healing

P304

1497-1506

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.25478

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

127

http://www.w3.org/2001/XMLSchema#string

P577

2010-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44631058

http://www.w3.org/2001/XMLSchema#string

P698

20503271

http://www.w3.org/2001/XMLSchema#string